46.4 - FDA Efforts to Advance Racial and Ethnic Minority Participation in Clinicals Trials
Saturday, April 2, 2022
2:13 PM – 2:33 PM
Room: 114 (Nutter Auditorium) - Pennsylvania Convention Center
Introduction: This symposium aims to increase awareness of the ongoing and pervasive issues surrounding inequality in clinical trial development and provide insights on how these factors impact the validity and use of clinical trial results that currently perpetuate health disparities. This symposium will highlight the pharmacological insights and novel strategies to diversify scientific approaches involved in pharmacotherapeutic clinical trial design, execution and outcome analysis to overcome barriers for patients from underrepresented populations. The symposium will provide unique perspectives from leaders in the field of pharmacology representing a broad range of disciplines (industry, academia, government). The speakers have been selected based on their alignment with pharmacological scientific approaches and will present on topics of interest to a broad group of preclinical and clinical pharmacologists.
